DASH Prediction Score for Recurrent VTE
Predicts likelihood of recurrence of first VTE.
Do NOT use in patients with active hemorrhage or signs/symptoms of VTE.
Management
In a patient with previously diagnosed VTE who has completed a 3-6 month course of anticoagulation:
- DASH ≤1:
- Consider discontinuing anticoagulation, as this group has an annual recurrence risk of 3.1%.
- DASH ≥2:
- Consider continuing anticoagulation, as this group has an annual recurrence risk of 9.3%.
Critical Actions
- No decision rule should trump clinical gestalt. Consider the clinical scenario before continuing or discontinuing anticoagulation for VTE.
- The DASH Score is meant to be applied to stable patients. It should not be applied to patients with active hemorrhage or those with signs and symptoms of VTE.